ENVERIC BIOSCIENCES INC

Historical 13F Holders

Symbol
ENVB
CUSIP
29405E505
All holders as of
Q2 2026
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 29405E505 since 12/18/2024, newest first.

Filer % of Class Filed
Armistice Capital, LLC 13G
10.0% 8/14/2026
Event 6/30/2026
Lind Global Fund III LP 13G/A Amendment 2
1.4% 8/14/2026
Event 6/30/2026
Ayrton Capital LLC 13G/A Amendment 1
2.9% 8/13/2026
Event 6/30/2026
Lind Global Fund III LP 13G/A Amendment 1
7.9% 5/15/2026
Event 3/31/2026
Lind Global Fund III LP 13G
10.0% 2/4/2026
Event 1/28/2026
Intracoastal Capital LLC 13G
4.99% 2/2/2026
Event 1/27/2026
Intracoastal Capital, LLC 13G
4.99% 12/17/2025
Event 12/11/2025
Braeden Lichti 13G/A Amendment 1
0% 12/10/2025
Event 12/9/2025
Northstrive Fund II LP 13G/A Amendment 1
0% 12/10/2025
Event 12/9/2025
Braeden Lichti 13G
5.0% 12/5/2025
Event 12/3/2025
Northstrive Fund II LP 13G
5.0% 12/5/2025
Event 12/3/2025
Ayrton Capital LLC 13G
10.0% 11/13/2025
Event 9/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 23 527 k $733 k
2026 Q1 11 55.0 k $107 k
2025 Q4 11 24.2 k $87.7 k